FIELD: medicine.
SUBSTANCE: invention relates to a method of depositing lutein and/or zeaxanthin in eye tissues, as well as a method of treating, relieving or preventing ocular disease or functional disorder. Method for deposition of lutein and/or zeaxanthin involves steps of producing a liposome containing lutein and/or zeaxanthin in amounts effective to increase levels of the macular pigment in eye tissues of a subject, charging the iontophoresis device with a liposome composition containing lutein and/or zeaxanthin, applying the iontophoresis device on the subject's eye and bringing the iontophoresis device into action.
EFFECT: technical result is developing a minimally invasive method of moving high concentrations of charged lutein through sclera and/or through the cornea by iontophoresis.
6 cl, 5 tbl, 4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POSITIVELY CHARGED LIPOSOMES AS LIPOPHILIC CARRIER MOLECULES | 2017 |
|
RU2718065C2 |
| COMPOSITIONS AND METHODS FOR INSERTION OF TUBULIN-BINDING AGENTS FOR EYE DISEASE THERAPY | 2002 |
|
RU2354398C2 |
| COMPOSITIONS AND WAYS OF INJECTIONS OF AGENTS BINDING TUBULIN, FOR TREATMENT OF EYE DISEASES | 2004 |
|
RU2359693C2 |
| TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS | 2018 |
|
RU2815482C2 |
| INHIBITORS OF HYSTONE DEACETYLASE FOR TREATMENT OF DEGENERATIVE EYE DISEASES | 2003 |
|
RU2324483C2 |
| NUTRICEUTICAL OPHTHALMOLOGICAL COMPOSITION FOR TREATMENT OF RETINAL PATHOLOGIES WITH A NEOVASCULAR COMPONENT | 2019 |
|
RU2806096C2 |
| OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITIONS FOR NEOANGIOGENIC EYE PATHOLOGIES | 2009 |
|
RU2519739C2 |
| INTEGRIN RECEPTOR ANTAGONISTS AND USE THEREOF | 2012 |
|
RU2721907C2 |
| EYE IMPLANTAT PREPARED BY DOUBLE EXTRUSION METHOD | 2005 |
|
RU2389479C2 |
| METHOD FOR EARLY DIAGNOSIS OF PRIMARY OPEN-ANGLE GLAUCOMA | 2019 |
|
RU2698931C1 |
